Rankings
▼
Calendar
PCRX FY 2008 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena
PCRX
Pacira BioSciences, Inc.
$976M
FY 2008 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$14M
Gross Profit
-$4M
-25.4% margin
Operating Income
-$45M
-325.8% margin
Net Income
-$42M
-300.6% margin
EPS (Diluted)
$-79.23
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$35M
Stock-Based Comp.
$242,000
Balance Sheet
Total Assets
$51M
Total Liabilities
$43M
Stockholders' Equity
$7M
Cash & Equivalents
$12M
← FY 2009
All Quarters